Please assess the completion status of the following clinical trial:

Trial Title: Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* Age ≥ 18~* Able to give informed consent~* Scheduled for surgery at Brigham and Women's Hospital for known or highly suspected Stage III or IV ovarian cancer (i.e. elevated CA-125 with a pelvic mass, ascites, and carcinomatosis)~* Post-menopausal or negative urine and/or blood pregnancy test~* Measurable disease on preoperative imaging~Exclusion Criteria:~* Male~* Age \< 18~* Unable to give informed consent~* Not planned for surgical intervention~* Active malignancy other than ovarian cancer~* Prior bilateral tubal ligation or hysterectomy (as this would prevent chromopertubation)~* Known or suspected active pelvic infection~* Pregnancy~* No measurable disease or suspected Stage I or II ovarian cancer on preoperative imaging

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Culdocentesis (Type: EXPERIMENTAL): * Patients with known or highly likely ovarian cancer (i.e. highly elevated CA-125, ascites, pelvic mass) scheduled for cytoreductive surgery will be identified during preoperative consultation and offered participation in the study.~* During Surgery:~  * Blood Collection~ * Vaginal Swab~ * Chromopertubation~ * Culdocentesis~ * Tissue Collection

Based on this trial design, predict the completion outcome and termination type (if applicable).